Artemisinins are very poweful tools in the treatment of malaria, and the emerging loss of their activity has the potential to create a major public health problem. MALARIA TREATMENT
Dr Charlie Woodrow is based at MORU in Bangkok, Thailand, where he coordinates clinical and laboratory studies on resistance to artemisinins. Bringing together diverse datasets of clinical, in vitro and molecular data has helped better understand the emerging resistance, particularly in Myanmar.
Podden och tillhörande omslagsbild på den här sidan tillhör
Oxford University. Innehållet i podden är skapat av Oxford University och inte av,
eller tillsammans med, Poddtoppen.
